Minerva Neurosciences, Inc: Minerva Neurosciences Reports 20

Company to host conference call today at 8:30 a.m. ETBURLINGTON, Mass., May 15, 2023(Nasdaq: NERV), a clinical-stage biopharmaceutical company focused on the development of therapies to treat central nervous

Related Keywords

Frederick Ahlholm , Minerva Neurosciences , Remy Luthringer , Helen Shik , Exchange Commission On , Minerva Neurosciences Inc , Exchange Commission , Shik Communications , Drug Administration , Nasdaq , New Drug Application , Prescription Drug User Fee Act , Executive Chairman , Chief Executive Officer , Formal Dispute Resolution Request , Royalty Pharma , Federal Food Drug , Cosmetic Act , Call Information , Private Securities Litigation Reform Act , Annual Report , Quarterly Report , Term Liabilities , Months Ended December , Gefallene Big Techs , Aminerva , Neurosciences , Reports , 023 , First , Quarter , Financial , Results , Business , Updates ,